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Adolescence is a time of  transition between child-hood and adult life and 
adolescent well care visits are 
important to support adolescents’ 
transition to adult health care. 
These visits provide an opportunity 
for young adults to speak to a non-
parental adult about health and 
social issues that concern them. 
A variety of guidance is available 
on the content of the well adoles-
cent visit. Since adolescents and 
young adults have the highest rates 
of several STIs when compared 
with any other age group, this 
article will focus on sexually trans-
mitted disease/sexually transmitted 
infection (STD/STI) and human 
immunodeficiency virus (HIV) 
screening recommendations. 
There are many aspects to STD/STI 
and HIV screening for adolescents. 
It is also important to understand 
the legal aspects of screening 
minors in Iowa. Electronic health 
records, confidentiality, and  
billing issues can raise questions  
for providers.
Legal Aspects of Screening 
Minors in Iowa
Age of Majority
Iowa law generally provides that a 
person under the age of 18 years is 
a minor. However, persons who are 
married prior to the age of 18 years 
and persons who are tried and 
incarcerated as adults are deemed 
to have attained the age of major-
ity. Iowa Code § 599.1. See also Iowa 
Code §§ 135L.1(7), 239B.1(9), 
600A.2(12), 728.1(4).
Specific Type of Service  
and Care for which Minors  
can Consent:
Iowa law contains several provi-
sions that govern a minor’s ability 
to consent to health care and ser-
vices. Every state allows teens to be 
tested and treated for STIs without 
parental consent. The Health 
Insurance Portability and Account-
ability Act (HIPAA) Privacy Rule 
specifies the circumstances in 
which the parent is not the  
“personal representative” with 
respect to certain health informa-
tion about his or her minor child. 
These exceptions generally track 
the ability of minors to obtain spe-
cific health care without parental 
consent under state or other laws, 
or standards of professional prac-
tice. In these situations, the parent 
does not control the minor’s health 
care decisions, and thus under  
the Rule, does not control the  
protected health information 
related to that care.  
 
Early & Periodic Screening, Diagnosis & Treatment
Recommendations for Adolescent  
STD/STI and HIV Screening
 EPSDT Care for Kids Newsletter    Spring 2016   http://www.iowaepsdt.org  
 EPSDT Care for Kids Newsletter    Spring 2016   http://www.iowaepsdt.org  
• 2 •




Consent for Contraceptive 
Services
In Iowa minors are able to consent 
to contraceptive services. Providers 
are not required to obtain consent 
from a parent or guardian prior to 
providing contraceptive services to 
a minor. The relevant portion of the 
text of the law provides as follows:
A person may apply for…contra-
ceptive services…directly to a 
licensed physician and surgeon, 
an osteopathic physician and 
surgeon, or a family planning 
clinic. ….The minor shall give 
written consent to these proce-
dures and to receive the services, 
screening, or treatment. Such 
consent is not subject to later dis-
affirmance by reason of minority. 
Iowa Code § 141A.7 (3). See also 
Carey v. Population Services, 
International, 431 U.S. 678 (1977); 
Title X Family Planning Program.
Consent for Care for Sexually 
Transmitted Diseases
Iowa law authorizes a minor to 
provide consent for medical ser-
vices related to the prevention, 
diagnosis, or treatment of a sexu-
ally transmitted disease. Minors are 
able to provide consent for preven-
tion services such as the hepatitis B 
(HBV) vaccine, and for treatment  
for STDs including chlamydia,  
gonorrhea, HBV, hepatitis C, human 
papillomavirus (HPV), and syphilis. 
A health care provider is not 
required to obtain consent from a 
parent or guardian prior to provid-
ing these services to a minor.
The text of the law provides  
as follows:
A minor shall have the legal 
capacity to act and give consent 
to provision of medical care or 
services to the minor for the pre-
vention, diagnosis or treatment of 
a sexually transmitted disease or 
infection by a hospital, clinic or 
health care provider. Such 
medical care or services shall be 
provided by or under the supervi-
sion of a physician licensed to 
practice medicine and surgery or 
osteopathic medicine and 
surgery, a physician assistant or 
an advanced registered nurse 
practitioner. Consent shall not be 
subject to later disaffirmance by 
reason of such minority. The 
consent of another person, includ-
ing but not limited to the consent 
of a spouse, parent, custodian or 
guardian, shall not be necessary. 
Iowa Code § 139A.35.
HIV/AIDS Care
Iowa law authorizes a minor to give 
consent to receive services, screen-
ing, testing, and treatment for HIV 
and acquired immune deficiency 
syndrome (AIDS), and provides that 
the consent of a parent or guardian 
is not required to provide these  
services. However, the law does 
require that a minor must be 
informed prior to testing that if the 
test result is positive the minor’s 
legal guardian shall be informed by 
the testing facility unless a testing 
facility is precluded by federal 
statute, regulation, or Centers for 
Disease Control and Prevention 
guidelines from informing the  
legal guardian. The text of the law  
provides as follows:
Notwithstanding any other provi-
sion of law, however, a minor 
shall be informed prior to testing 
that, upon confirmation accord-
ing to prevailing medical 
technology of a positive HIV-
related test result, the minor’s 
legal guardian is required to be 
informed by the testing facility. 
Testing facilities where minors are 
tested shall have available a 
program to assist minors and 
legal guardians with the notifica-
tion process which emphasizes 
the need for family support and 
assists in making available the 
resources necessary to accomplish 
that goal. However, a testing facil-
ity which is precluded by federal 
statute, regulation, or Centers for 
Disease Control and Prevention 
guidelines from informing the 
legal guardian is exempt from the 
notification requirement. The 
minor shall give written consent 
to these procedures and to receive 
the services, screening or treat-
ment. Such consent is not subject 
to later disaffirmance by reason of 
minority. Iowa Code § 141A.7(3). 
(Title X family planning clinics are 
precluded from informing the 
legal guardian, for example).
Opt-out testing is available for 
adults in Iowa. Specifically, written 
consent is not required for HIV 
testing of adults. Minors must give 
written consent for HIV testing and 
treatment services. The consent 
form should indicate that the minor 
understands that his or her legal 
guardian will be notified if the test 
is confirmed as positive.
 EPSDT Care for Kids Newsletter    Spring 2016   http://www.iowaepsdt.org  
• 3 •
Billing for Services
Third-party reimbursement for 
screening services also can create 
challenges. Many adolescents are 
covered by public or private insur-
ance, but are unwilling or unable to 
use their coverage for reproductive 
health services, or other sensitive 
issues, because they worry that 
their parents will find out through 
the billing and insurance claims 
process. In Iowa, if the minor is a 
Medicaid recipient, he or she is 
entitled to receive confidential 
family planning and related ser-
vices if the services are billed to 
Medicaid. The Medicaid Managed 
Care Organizations also will be  
held to this standard. Minors not  
on Medicaid may be eligible to 
receive confidential services under 
Iowa’s Family Planning Waiver  
(Iowa Family Planning Network). 
The Iowa Family Planning Waiver 
program is a Medicaid adminis-
tered program with specific income 
and other eligibility requirements. 
http://dhs.iowa.gov/sites/default/
files/IFPN_0.pdf
The HIPAA privacy rule provides a 
legal basis for a minor to request 
that providers and health plans 
restrict disclosure of their protected 
health information or that they  
communicate with the minor in a 
confidential manner. The effective 
implementation of these provisions 
requires the willing and active 
cooperation of both health care 
providers and third-party payers. 
Most minors will not be aware of 
this right and will need to be 
informed and encouraged to follow 
the plan’s guidance for requesting 
suppression of their protected 
health information. 
Electronic Health Records 
and Confidentiality
In 2012 the American Academy  
of Pediatrics (AAP) issued a policy 
statement on Standards for  
Health Information Technology  
to Ensure Adolescent Privacy,  
http://pediatrics.aappublications.
org/content/130/5/987. In it the 
AAP suggests steps necessary to 
keep protected health information 
confidential for minors. HIPAA rules 
defer to state law regarding minors 















Age 15-19 1243 453 2075
Age 20-24 2263 1215 3375
Gonorrhea
Age 15-19 143 82 207
Age 20-24 249 222 278
Syphilis – Primary/
Secondary/Early latent
Age 15-19 3 2 4
Age 20-24 14 27 1
Table 1.  Statewide incidence rates of select STDs  









15-24 18 5 373
Table 2.  Number of youth diagnosed with HIV or AIDS and those  
 living  with HIV (prevalence) (Age group 15-24), 2014 data
(e.g., adolescents seeking care  
for STIs) and gives the minor and 
not the parent the right to their 
protected health information.  
The rules have not resulted in all 
commercial health information 
technology systems having the 
capability to protect this informa-
tion. Providers must make every 
effort to assure that minors seeking 
confidential services are protected 
from inadvertent release of infor-
mation through patient portals.




(continues on page 4)
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Screening Guidelines for Non-Pregnant Adolescents and Young Adults
Table 3. Comparison of STI screening recommendations for sexually active non-pregnant women  
(adapted from USPSTF). AAFP generally follows USPSTF. For specific guidance, see the links on page seven.
Agency Recommendations
US Preventive 
Services Task Force 
(USPSTF)
Screen women younger than 25 years and others at increased risk.
Centers for Disease 
Control and 
Prevention (CDC)
Screen women 25 years and younger and others at increased risk.
Evidence is insufficient to recommend routine screening for C. trachomatis in sexually  
active young men based on feasibility, efficacy, and cost-effectiveness. However, screening 
of sexually active young men should be considered in clinical settings associated with  
high prevalence of chlamydia (e.g., adolescent clinics, correctional facilities, and STD clinics) 
and should be offered to young men who have sex with men (YMSM). 
American Academy 
of Family Physicians 
(AAFP)
Screen women 25 years and younger and others at increased risk.
Current evidence is insufficient to assess the balance of benefits and harms of screening  
for chlamydia and gonorrhea in men. 
American Congress 
of Obstetrics and 
Gynecologists 
(ACOG)
Screen women younger than 25 years and others at increased risk.
AAP Screen sexually active women 25 and younger annually; screen all adolescent men who 
have sex with men (MSM).
Males who have high-risk sex with males (multiple or anonymous partners, illicit drug use) 
should be screened every 3-6 months. Males in correctional facilities, jails, job training 
programs, STD clinics, and school clinics should be screened. Screen all youth who have 
been exposed to chlamydia from a partner within 60 days.
Chlamydia
Agency Recommendations
USPSTF Do not screen general population.
CDC Provide pre-vaccination screening for women at increased risk.
AAFP Do not screen general population.
ACOG Screen women at increased risk.
AAP Routine screening not recommended but testing for chronic infection appropriate  
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Agency Recommendations
USPSTF Screen women younger than 25 years and others at increased risk. 
CDC Annual screening for all sexually active women age <25 years.
Screening should be offered to YMSM and in geographic locations where gonococcal 
infection is concentrated.
AAFP Screen women 25 years and younger and others at increased risk.
Current evidence is insufficient to assess the balance of benefits and harms of screening  
for chlamydia and gonorrhea in men.
ACOG Test if age 25 years or younger and sexually active, and others at increased risk.
AAP Screen sexually active women 25 and younger annually.
Screen all males who have individual and population-based risk factors. Screen all  
youth who have been exposed to chlamydia from a partner within 60 days. 
Gonorrhea
Agency Recommendations
USPSTF Do not screen.
CDC Do not screen general population. 
AAFP Do not screen.
ACOG Screen if sexual partner has HSV. 
HSV (Herpes Simplex Virus)
Agency Recommendations
USPSTF Do not screen general population; insufficient evidence to recommend  
for or against screening women at increased risk.
CDC Screen women at increased risk. 
AAFP Do not screen general population; insufficient evidence to recommend  
for or against screening women at increased risk.
ACOG Screen women at increased risk. 
AAP Routine screening not recommended; screen as appropriate to patient  
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Agency Recommendations
USPSTF Insufficient evidence to use as primary screening test for cervical cancer. 
CDC Do not screen for subclinical infection. 
AAFP Insufficient evidence to use as primary screening test for cervical cancer.
ACOG Testing with a Pap smear is an option for women older than 30 years.
HPV
Agency Recommendations
USPSTF Screen sexually active, non-pregnant women at risk of HIV infection beginning at age 15.
CDC Screen patients aged 13–64 years in all health care settings.
Persons should be notified that testing will be performed, but retain the option to  
decline or defer testing (an opt-out approach).
AAFP Screen adolescents and adults ages 18 to 65 years for HIV infection.
Younger adolescents and older adults who are at increased risk should also be screened. 
ACOG All females ages 13 to 64 should be tested at least once in their lifetime;  
annual re-testing is recommended based on individual risk factors.
Physicians should be aware of and follow their states’ HIV screening requirements. 
AAP Bright Futures 2015–routine screening between ages 16-18; annual testing if high risk.
HIV
Agency Recommendations
USPSTF Screen women at increased risk.
CDC Screen women exposed to syphilis. 
AAFP Screen women at increased risk. 
ACOG Sexually active adolescents who exchange sex for drugs or money, use intravenous drugs, 
are entering a detention facility, or live in a high-prevalence area.
AAP Routine screening not recommended.
All sexually active adolescents should be screened annually or every 3-6 months if they are 








USPSTF Guidelines from USPSTF and ACOG recommend that cervical cancer screening begin  
at age 21 years (a recommendation based on the low incidence of cervical cancer and 
limited utility of screening for younger adolescents).
Absence of cervical cancer screening should not delay initiation or continuation of  
a contraceptive method. 
CDC Women aged <21 years should not be screened regardless of the age of sexual initiation  
or other risk factors. 
AAFP Cervical cancer screening between 21 to 65 years with cytology (Pap smear) every 3 years 
or, for women age 30 to 65 years who want to lengthen the screening interval, screen  
with a combination of cytology and human papillomavirus (HPV) testing every 5 years.
ACOG Cervical cancer screening begins at age 21 years; screen every 3 years with cytology alone.
Absence of cervical cancer screening should not delay initiation or continuation of a 
contraceptive method.
AAP Cervical cancer screening begins at age 21 years.
Agency Recommendations
CDC The routine screening of adolescents who are asymptomatic for certain STDs  
(e.g., syphilis, trichomonas, bacterial vaginosis, HSV, HPV, hepatitis A (HAV), and HBV)  
is not recommended. However, YMSM, youth in correctional facilities, and those living  
in communities with high prevalence of infections and pregnant adolescent females  
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University of Iowa Children’s Hospital
Center for Disabilities and Development
University Center for Excellence on Disabilities
100 Hawkins Drive
Iowa City, IA 52242-1011
The  EPSDT Care for Kids Newsletter  is published 
three times a year, in print and online, as a joint 
effort of the Iowa Prevention of Disabilities Policy 
Council, the Iowa Department of Human Services, 
the Iowa Department of Public Health, and the 
Center for Disabilities and Development, which is 
nationally designated as Iowa’s University Center for 
Excellence on Disabilities. The goal of this newsletter 
is to inform Iowa health care professionals about 
the EPSDT Care for Kids program, to encourage 
them to make use of this important resource, and 
to provide them with information about a wide 








If you have questions about billing related to EPSDT Care for Kids services, please call Provider 
Services: 1-800-338-7909. If you have questions about clinical issues and EPSDT Care for Kids 
services, please call 1-800-383-3826. Please note: Due to budget restraints, the EPSDT Care for 
Kids Newsletter is sent to offices and organizations, rather than to individuals. The newsletter is 
also available on line at www.iowaepsdt.org. Readers are welcome to photocopy or down-
load material from the newsletter to share with others. If you wish to reproduce material from the 
newsletter in another publication, whether print or electronic, please obtain permission prior to 
publication by contacting the editor. Please include the following acknowledgment with reprinted 
material: Reprinted by permission of the Iowa EPSDT Care for Kids Newsletter.
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Development Room 257    
100 Hawkins Drive
Iowa City, IA 52242-1011
New look for EPSDT Care for Kids web site
Iowa’s EPSDT Care for Kids health provider web site has been given  
a new look and format. The new site provides you with the latest news  
in a format that is interactive, making it easier for you to find key 
program information. Check it out and provide us with your feedback 
at www.iowaepsdt.org.
